BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3201471)

  • 1. Generation of hypophosphatemia in rats by continuous oral administration of cadmium.
    Ando M; Matsui S; Jinno H; Sayato Y; Takeda M
    Toxicology; 1988 Dec; 53(1):1-10. PubMed ID: 3201471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of cyclic AMP in cadmium-intoxicated rats.
    Ando M; Matsui S; Jinno H; Takeda M
    J Toxicol Environ Health; 1989; 27(3):307-15. PubMed ID: 2547079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cadmium on the metabolism of vitamin D3 in rats.
    Ando M; Shimizu M; Matsui S; Sayato Y; Takeda M
    Toxicol Appl Pharmacol; 1987 Jun; 89(2):158-64. PubMed ID: 3037727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effect of vitamin D metabolites: evidence for the essential role of the 25(OH) group.
    Friedlaender MM; Kornberg Z; Wald H; Popovtzer MM
    Am J Physiol; 1983 Jun; 244(6):F674-8. PubMed ID: 6602555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has vitamin D a direct renal effect on the tubular reabsorption of phosphate? A study in parathyroidectomized (PTX) and non-PTX man.
    Madsen S; Olgaard K
    Adv Exp Med Biol; 1978; 103():111-23. PubMed ID: 717102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for acute inhibitory effects in vivo of 1 alpha-hydroxycholecalciferol on parathyroid hormone secretion in rats.
    Kugai N; Koide Y; Kimura S; Yamashita K; Ogata E
    Endocrinology; 1981 Oct; 109(4):1078-83. PubMed ID: 6269831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
    Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
    Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcemic response to parathyroid hormone in renal failure: role of calcitriol and the effect of parathyroidectomy.
    Rodriguez M; Felsenfeld AJ; Llach F
    Kidney Int; 1991 Dec; 40(6):1063-8. PubMed ID: 1762307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial calcifications in uraemic rats treated with 1-alpha-hydroxycholecalciferol and parathyroidectomy.
    Krog M; Ejerblad S; Eriksson I; Johansson H
    Scand J Urol Nephrol; 1984; 18(3):227-39. PubMed ID: 6494830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral phosphorus supplementation on mineral metabolism of renal transplant recipients.
    Caravaca F; Fernández MA; Ruiz-Calero R; Cubero J; Aparicio A; Jimenez F; García MC
    Nephrol Dial Transplant; 1998 Oct; 13(10):2605-11. PubMed ID: 9794568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocalcemia, but not PTH or hypophosphatemia, induces a rapid increase in 1,25(OH)2D3 levels in rats.
    Fox J
    Am J Physiol; 1992 Feb; 262(2 Pt 1):E211-5. PubMed ID: 1539647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations.
    Hove K; Horst RL; Littledike ET; Beitz DC
    Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Ca2+ modulates responsiveness of renal 25(OH)D3-1 alpha-hydroxylase to PTH in rats.
    Matsumoto T; Ikeda K; Morita K; Fukumoto S; Takahashi H; Ogata E
    Am J Physiol; 1987 Nov; 253(5 Pt 1):E503-7. PubMed ID: 2825531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.
    Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F
    Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
    Brandi L; Daugaard H; Nielsen PK; Jensen LT; Egsmose C; Olgaard K
    Nephron; 1996; 74(1):89-103. PubMed ID: 8883025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 1,25-dihydroxyvitamin D3 on intestinal phosphate absorption in rats with a normal vitamin D supply.
    Rizzoli R; Fleisch H; Bonjour JP
    J Clin Invest; 1977 Sep; 60(3):639-47. PubMed ID: 893667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-level lifetime exposure to cadmium on calciotropic hormones in aged female rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Arch Toxicol; 2005 Nov; 79(11):636-46. PubMed ID: 15940469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration.
    Fournier A; Morinière PH; Oprisiu R; Yverneau-Hardy P; Westeel PF; Mazouz H; el Esper N; Ghazali A; Boudailliez B
    Nephron; 1995; 71(3):254-83. PubMed ID: 8569975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.